Effect on pseudoconditioning of drugs with known central nervous activity.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology; D002188:Cannabis / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003213:Conditioning, Psychological / Q000187:drug effects*; D003864:Depression, Chemical; D003975:Diazepam / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D005260:Female; D008620:Meprobamate / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013331:Strychnine / Q000494:pharmacology; D014293:Trimethadione / Q000494:pharmacology
D000654:Amobarbital; D002110:Caffeine; D002746:Chlorpromazine; D003975:Diazepam; D003983:Dibenzylchlorethamine; D008620:Meprobamate; D010433:Pentylenetetrazole; D010634:Phenobarbital; D010672:Phenytoin; D010852:Picrotoxin; D013331:Strychnine; D014293:Trimethadione